SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?


To: Tom Hua who wrote (689)1/14/1998 10:21:00 PM
From: Tech Master  Respond to of 3578
 
Tom-

I believe that there is merit to the enzyme findings, however, the near term for this stock is flat to down.... probably the 8-11 range. Long positions should be built on weakness when the stock returns to these levels. There is nothing in the fundamentals to support these/higher share prices over the next few quarters. This discovery may also lead other researchers to make similar discoveries which may complete with Geron's findings.

Just my opinions,

Tech Master